PROGYNY INC (PGNY) Fundamental Analysis & Valuation

NASDAQ:PGNY • US74340E1038

Current stock price

16.86 USD
-0.12 (-0.71%)
Last:

This PGNY fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

7

1. PGNY Profitability Analysis

1.1 Basic Checks

  • PGNY had positive earnings in the past year.
  • PGNY had a positive operating cash flow in the past year.
  • Each year in the past 5 years PGNY has been profitable.
  • In the past 5 years PGNY always reported a positive cash flow from operatings.
PGNY Yearly Net Income VS EBIT VS OCF VS FCFPGNY Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50M 100M 150M 200M

1.2 Ratios

  • PGNY has a better Return On Assets (7.88%) than 90.00% of its industry peers.
  • PGNY's Return On Equity of 11.34% is fine compared to the rest of the industry. PGNY outperforms 74.00% of its industry peers.
  • The Return On Invested Capital of PGNY (10.67%) is better than 82.00% of its industry peers.
  • Measured over the past 3 years, the Average Return On Invested Capital for PGNY is in line with the industry average of 8.74%.
  • The last Return On Invested Capital (10.67%) for PGNY is above the 3 year average (9.10%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 7.88%
ROE 11.34%
ROIC 10.67%
ROA(3y)8.34%
ROA(5y)9.8%
ROE(3y)11.81%
ROE(5y)13.92%
ROIC(3y)9.1%
ROIC(5y)7.81%
PGNY Yearly ROA, ROE, ROICPGNY Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -50 -100

1.3 Margins

  • PGNY has a Profit Margin of 4.54%. This is in the better half of the industry: PGNY outperforms 75.00% of its industry peers.
  • In the last couple of years the Profit Margin of PGNY has declined.
  • PGNY has a Operating Margin of 7.06%. This is in the better half of the industry: PGNY outperforms 71.00% of its industry peers.
  • In the last couple of years the Operating Margin of PGNY has grown nicely.
  • PGNY has a Gross Margin (23.63%) which is in line with its industry peers.
  • In the last couple of years the Gross Margin of PGNY has grown nicely.
Industry RankSector Rank
OM 7.06%
PM (TTM) 4.54%
GM 23.63%
OM growth 3Y33.54%
OM growth 5Y21.46%
PM growth 3Y5.54%
PM growth 5Y-19.56%
GM growth 3Y3.58%
GM growth 5Y3.06%
PGNY Yearly Profit, Operating, Gross MarginsPGNY Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10 -10 20 -20

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

10

2. PGNY Health Analysis

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), PGNY is creating some value.
  • The number of shares outstanding for PGNY has been reduced compared to 1 year ago.
  • The number of shares outstanding for PGNY has been reduced compared to 5 years ago.
  • There is no outstanding debt for PGNY. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
PGNY Yearly Shares OutstandingPGNY Yearly Shares OutstandingYearly Shares Outstanding 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M
PGNY Yearly Total Debt VS Total AssetsPGNY Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M

2.2 Solvency

  • An Altman-Z score of 6.77 indicates that PGNY is not in any danger for bankruptcy at the moment.
  • Looking at the Altman-Z score, with a value of 6.77, PGNY belongs to the top of the industry, outperforming 93.00% of the companies in the same industry.
  • There is no outstanding debt for PGNY. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 6.77
ROIC/WACC1.19
WACC8.99%
PGNY Yearly LT Debt VS Equity VS FCFPGNY Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 100M 200M 300M 400M 500M

2.3 Liquidity

  • PGNY has a Current Ratio of 2.73. This indicates that PGNY is financially healthy and has no problem in meeting its short term obligations.
  • Looking at the Current ratio, with a value of 2.73, PGNY belongs to the top of the industry, outperforming 84.00% of the companies in the same industry.
  • A Quick Ratio of 2.73 indicates that PGNY has no problem at all paying its short term obligations.
  • With an excellent Quick ratio value of 2.73, PGNY belongs to the best of the industry, outperforming 84.00% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.73
Quick Ratio 2.73
PGNY Yearly Current Assets VS Current LiabilitesPGNY Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

7

3. PGNY Growth Analysis

3.1 Past

  • PGNY shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 14.04%, which is quite good.
  • The Earnings Per Share has been growing by 52.04% on average over the past years. This is a very strong growth
  • PGNY shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 10.40%.
  • Measured over the past years, PGNY shows a very strong growth in Revenue. The Revenue has been growing by 30.16% on average per year.
EPS 1Y (TTM)14.04%
EPS 3Y29.4%
EPS 5Y52.04%
EPS Q2Q%16.67%
Revenue 1Y (TTM)10.4%
Revenue growth 3Y17.87%
Revenue growth 5Y30.16%
Sales Q2Q%6.69%

3.2 Future

  • The Earnings Per Share is expected to grow by 27.30% on average over the next years. This is a very strong growth
  • PGNY is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 5.69% yearly.
EPS Next Y62.1%
EPS Next 2Y38.14%
EPS Next 3Y36.62%
EPS Next 5Y27.3%
Revenue Next Year7.67%
Revenue Next 2Y8.64%
Revenue Next 3Y7.86%
Revenue Next 5Y5.69%

3.3 Evolution

  • Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
PGNY Yearly Revenue VS EstimatesPGNY Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 500M 1B 1.5B
PGNY Yearly EPS VS EstimatesPGNY Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 0.5 1 1.5 2

More info and screens

Find the best growth stocksShow best growing peers

6

4. PGNY Valuation Analysis

4.1 Price/Earnings Ratio

  • With a Price/Earnings ratio of 25.94, PGNY can be considered very expensive at the moment.
  • Compared to the rest of the industry, the Price/Earnings ratio of PGNY is on the same level as its industry peers.
  • PGNY is valuated at similar levels of the S&P average when we compare the Price/Earnings ratio to 25.35, which is the current average of the S&P500 Index.
  • With a Price/Forward Earnings ratio of 16.00, PGNY is valued correctly.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of PGNY indicates a somewhat cheap valuation: PGNY is cheaper than 67.00% of the companies listed in the same industry.
  • PGNY's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 22.61.
Industry RankSector Rank
PE 25.94
Fwd PE 16
PGNY Price Earnings VS Forward Price EarningsPGNY Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, PGNY is valued a bit cheaper than 75.00% of the companies in the same industry.
  • Based on the Price/Free Cash Flow ratio, PGNY is valued cheaper than 89.00% of the companies in the same industry.
Industry RankSector Rank
P/FCF 7.2
EV/EBITDA 9.2
PGNY Per share dataPGNY EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15

4.3 Compensation for Growth

  • PGNY's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • The decent profitability rating of PGNY may justify a higher PE ratio.
  • PGNY's earnings are expected to grow with 36.62% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.42
PEG (5Y)0.5
EPS Next 2Y38.14%
EPS Next 3Y36.62%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. PGNY Dividend Analysis

5.1 Amount

  • No dividends for PGNY!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

PGNY Fundamentals: All Metrics, Ratios and Statistics

PROGYNY INC

NASDAQ:PGNY (4/1/2026, 9:52:26 AM)

16.86

-0.12 (-0.71%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)02-26
Earnings (Next)05-06
Inst Owners105.63%
Inst Owner Change0.54%
Ins Owners1.48%
Ins Owner Change3.15%
Market Cap1.38B
Revenue(TTM)1.29B
Net Income(TTM)58.52M
Analysts83.53
Price Target28.1 (66.67%)
Short Float %7.01%
Short Ratio3.56
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)4.44%
Min EPS beat(2)-5.34%
Max EPS beat(2)14.22%
EPS beat(4)2
Avg EPS beat(4)2.94%
Min EPS beat(4)-11.77%
Max EPS beat(4)14.63%
EPS beat(8)4
Avg EPS beat(8)4.01%
EPS beat(12)8
Avg EPS beat(12)21.97%
EPS beat(16)12
Avg EPS beat(16)74.68%
Revenue beat(2)2
Avg Revenue beat(2)2.09%
Min Revenue beat(2)1.53%
Max Revenue beat(2)2.66%
Revenue beat(4)4
Avg Revenue beat(4)2.33%
Min Revenue beat(4)1.53%
Max Revenue beat(4)3.19%
Revenue beat(8)5
Avg Revenue beat(8)0.19%
Revenue beat(12)8
Avg Revenue beat(12)0.58%
Revenue beat(16)10
Avg Revenue beat(16)0.45%
PT rev (1m)-8.73%
PT rev (3m)-5.34%
EPS NQ rev (1m)30.37%
EPS NQ rev (3m)6.67%
EPS NY rev (1m)10.6%
EPS NY rev (3m)-3.64%
Revenue NQ rev (1m)-6.3%
Revenue NQ rev (3m)-6.26%
Revenue NY rev (1m)-1.68%
Revenue NY rev (3m)-1.61%
Valuation
Industry RankSector Rank
PE 25.94
Fwd PE 16
P/S 1.07
P/FCF 7.2
P/OCF 6.57
P/B 2.68
P/tB 2.82
EV/EBITDA 9.2
EPS(TTM)0.65
EY3.86%
EPS(NY)1.05
Fwd EY6.25%
FCF(TTM)2.34
FCFY13.89%
OCF(TTM)2.57
OCFY15.22%
SpS15.73
BVpS6.3
TBVpS5.98
PEG (NY)0.42
PEG (5Y)0.5
Graham Number9.6
Profitability
Industry RankSector Rank
ROA 7.88%
ROE 11.34%
ROCE 16.85%
ROIC 10.67%
ROICexc 25.05%
ROICexgc 28.27%
OM 7.06%
PM (TTM) 4.54%
GM 23.63%
FCFM 14.88%
ROA(3y)8.34%
ROA(5y)9.8%
ROE(3y)11.81%
ROE(5y)13.92%
ROIC(3y)9.1%
ROIC(5y)7.81%
ROICexc(3y)21.68%
ROICexc(5y)17.45%
ROICexgc(3y)23.75%
ROICexgc(5y)19.08%
ROCE(3y)14.37%
ROCE(5y)12.33%
ROICexgc growth 3Y51.65%
ROICexgc growth 5Y21.09%
ROICexc growth 3Y48.79%
ROICexc growth 5Y23.47%
OM growth 3Y33.54%
OM growth 5Y21.46%
PM growth 3Y5.54%
PM growth 5Y-19.56%
GM growth 3Y3.58%
GM growth 5Y3.06%
F-Score6
Asset Turnover1.74
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 372.07%
Cap/Sales 1.43%
Interest Coverage 250
Cash Conversion 219.12%
Profit Quality 327.72%
Current Ratio 2.73
Quick Ratio 2.73
Altman-Z 6.77
F-Score6
WACC8.99%
ROIC/WACC1.19
Cap/Depr(3y)234.02%
Cap/Depr(5y)213.68%
Cap/Sales(3y)0.74%
Cap/Sales(5y)0.61%
Profit Quality(3y)315.29%
Profit Quality(5y)247.21%
High Growth Momentum
Growth
EPS 1Y (TTM)14.04%
EPS 3Y29.4%
EPS 5Y52.04%
EPS Q2Q%16.67%
EPS Next Y62.1%
EPS Next 2Y38.14%
EPS Next 3Y36.62%
EPS Next 5Y27.3%
Revenue 1Y (TTM)10.4%
Revenue growth 3Y17.87%
Revenue growth 5Y30.16%
Sales Q2Q%6.69%
Revenue Next Year7.67%
Revenue Next 2Y8.64%
Revenue Next 3Y7.86%
Revenue Next 5Y5.69%
EBIT growth 1Y34.87%
EBIT growth 3Y57.41%
EBIT growth 5Y58.1%
EBIT Next Year11.24%
EBIT Next 3Y9.76%
EBIT Next 5Y6.96%
FCF growth 1Y10.41%
FCF growth 3Y35.46%
FCF growth 5Y40.4%
OCF growth 1Y17.36%
OCF growth 3Y37.76%
OCF growth 5Y42.16%

PROGYNY INC / PGNY Fundamental Analysis FAQ

What is the fundamental rating for PGNY stock?

ChartMill assigns a fundamental rating of 7 / 10 to PGNY.


What is the valuation status of PROGYNY INC (PGNY) stock?

ChartMill assigns a valuation rating of 6 / 10 to PROGYNY INC (PGNY). This can be considered as Fairly Valued.


Can you provide the profitability details for PROGYNY INC?

PROGYNY INC (PGNY) has a profitability rating of 7 / 10.


What are the PE and PB ratios of PROGYNY INC (PGNY) stock?

The Price/Earnings (PE) ratio for PROGYNY INC (PGNY) is 25.94 and the Price/Book (PB) ratio is 2.68.


Can you provide the financial health for PGNY stock?

The financial health rating of PROGYNY INC (PGNY) is 10 / 10.